- Home
- CORT vs NIO Comparison
CORT vs NIO Comparison
Compare CORT & NIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CORT | NIO |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 12.4B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | CORT | NIO |
|---|---|---|
| Price | $83.28 | $4.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $130.20 | $6.73 |
| AVG Volume (30 Days) | 1.0M | ★ 42.1M |
| Earning Date | 11-04-2025 | 11-25-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.87 | N/A |
| Revenue | $741,172,000.00 | ★ $10,189,444,895.00 |
| Revenue This Year | $23.79 | $33.27 |
| Revenue Next Year | $40.97 | $50.24 |
| P/E Ratio | $93.87 | ★ N/A |
| Revenue Growth | ★ 17.92 | 14.90 |
| 52 Week Low | $49.00 | $3.02 |
| 52 Week High | $117.33 | $8.02 |
Technical Indicators
Market Signals| Indicator | CORT | NIO |
|---|---|---|
| Relative Strength Index (RSI) | 53.51 | 34.70 |
| Support Level | $80.38 | $4.86 |
| Resistance Level | $85.34 | $5.05 |
| Average True Range (ATR) | 3.54 | 0.13 |
| MACD | -0.38 | 0.05 |
| Stochastic Oscillator | 50.50 | 12.48 |
Price Performance
Historical ComparisonAbout CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About NIO NIO Inc. American depositary shares each representing one ordinary share
Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.